Cargando…
EphB4/ephrinB2 Contributes to Imatinib Resistance in Chronic Myeloid Leukemia Involved in Cytoskeletal Proteins
Introduction: The mechanism of EphB4/ephrinB2 in the resistance of chronic myelogenous leukemia to imatinib keeps unknown. Methods: The imatinib resistant chronic myelogenous leukemia cell line-K562-R, was established. EphB4 receptor expression was detected in patients and resistant cells. Cell migr...
Autores principales: | Li, Lin, Xu, Na, Zhang, Jin-fang, Xu, Lu-lu, Zhou, Xuan, Huang, Bin-tao, Li, Yu-ling, Liu, Xiao-li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879769/ https://www.ncbi.nlm.nih.gov/pubmed/27226777 http://dx.doi.org/10.7150/ijms.14989 |
Ejemplares similares
-
EphB/ephrinB Signaling in Cell Adhesion and Migration
por: Park, Inji, et al.
Publicado: (2015) -
EphB4/EphrinB2 therapeutics in Rhabdomyosarcoma
por: Randolph, Matthew E., et al.
Publicado: (2017) -
EphrinB2–EphB4 Signaling in Neurooncological Disease
por: Piffko, Andras, et al.
Publicado: (2022) -
Coexpression of EphB4 and ephrinB2 in tumour advancement of ovarian cancers
por: Alam, S M, et al.
Publicado: (2008) -
A morphogenetic EphB/EphrinB code controls hepatopancreatic duct formation
por: Thestrup, M. Ilcim, et al.
Publicado: (2019)